![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 16, 12143-12153, April 20, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Actinin-1 Interacts with the Metabotropic Glutamate Receptor Type 5b and Modulates the Cell Surface Expression and Function of the Receptor*
1






2
From the
Institut d'Investigacions Biomèdiques August Pi i Sunyer and Department of Biochemistry and Molecular Biology, University of Barcelona, Facultat de Biologia, Avda. Diagonal 645, Barcelona 08028, Spain, the
Medical Research Council Anatomical Neuropharmacology Unit, Oxford OX1 3TH, United Kingdom, and the ¶Department of Schizophrenia & Bipolar Neurophysiology and Pharmacology, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Harlow, Essex CM19 5AW, United Kingdom
Receptors for neurotransmitters require scaffolding proteins for membrane microdomain targeting and for regulating receptor function. Using a yeast two-hybrid screen,
-actinin-1, a major F-actin cross-linking protein, was identified as a binding partner for the C-terminal domain of metabotropic glutamate receptor type 5b (mGlu5b receptor). Co-expression, co-immunoprecipitation, and pull-down experiments showed a close and specific interaction between mGlu5b receptor and
-actinin-1 in both transfected HEK-293 cells and rat striatum. The interaction of
-actinin-1 with mGlu5b receptor modulated the cell surface expression of the receptor. This was dependent on the binding of
-actinin-1 to the actin cytoskeleton. In addition, the
-actinin-1/mGlu5b receptor interaction regulated receptor-mediated activation of the mitogen-activated protein kinase pathway. Together, these findings indicate that there is an
-actinin-1-dependent mGlu5b receptor association with the actin cytoskeleton modulating receptor cell surface expression and functioning.
Received for publication, September 15, 2006 , and in revised form, February 7, 2007.
* This work was supported by the Ministerio de Educación y Ciencia (Grant SAF2006-05481 to R. F., Grant SAF2005-00170 to E. C., and Grant SAF2005-00903 to F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 A Ph.D. student funded by GlaxoSmithKline (UK) and the Biotechnology and Biological Sciences and Research Council.
2 Recipient of a Ramón y Cajal research contract signed with the Ministerio de Educación y Ciencia. To whom correspondence should be addressed. Tel.: 34-934-039-280; Fax: 34-934-021-219; E-mail: fciruela{at}ub.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |